StreetAlpha.app
Home › Stocks › ETON

Eton Pharmaceuticals, Inc. (ETON)

$63.65
▼ −0.36%
LAST CLOSE · NOV 17

Eton develops and sells prescription treatments for rare diseases, mainly hormone and metabolic conditions. It last closed at $63.65 on Nov 17, down 0.36% on the day. ETON last reported earnings on Thu, Aug 13, 2026. The average 12-month price target from 3 analysts is $80.33 (+26.2% from the last close), with a high of $81.00 and a low of $80.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell).

AI Auto Pilots
Is ETON in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$141.1M
+100.6% vs a year ago
Net income
$49.9M
35.3% margin
EPS (diluted)
$1.54
Free cash flow
$38.2M
27.1% margin
Valuation
Market cap
$1.8B
28.8M shares
P/E
41.3
Price over 12 month EPS
Price to sales
13.0
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$55.6M
At Sep 30
Debt
$23.1M
At Sep 30
Shareholder equity
$86.9M
Shares outstanding
28.8M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $21.8M$21.8MFY2021FY2022: $21.3M$21.3MFY2022FY2023: $31.6M$31.6MFY2023FY2024: $39.0M$39.0MFY2024FY2025: $80.0M$80.0MFY2025

From ETON's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Aug 13
2026 · After the close (AMC)
Reported EPS
$0.35
vs $0.11 est. · beat
Year-ago EPS
—
Not on file
Options-implied move
±11.0%
Priced in before that report
Analyst consensus
Strong Buy
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Strong Buy
3firms
3 Buy0 Hold0 Sell
Each firm's latest rating on ETON in the past 90 days
Average 12-month target
$80.33
▲ 26.2% upside

Based on 3 analysts who set a price target on ETON in the past 90 days. The average target is $80.33, with a high of $81.00 and a low of $80.00, compared with the last close of $63.65.

Low $80.00Avg $80.33High $81.00
Blue marker: last close $63.65
Highest target$81.00
Average target$80.33
Lowest target$80.00
Latest rating changes
B. Riley SecuritiesTarget raised
Nov 10Buy$70 → $81
Canaccord GenuityTarget raised
Nov 6Buy$68 → $80
HC Wainwright & Co.Target raised
Nov 6Buy$70 → $80
Canaccord GenuityTarget raised
Aug 14Buy$60 → $68
B. Riley SecuritiesReiterated
Aug 14Buy$70
DateFirmActionRatingPrice target
Nov 10B. Riley SecuritiesTarget raisedBuy$70 → $81
Nov 6Canaccord GenuityTarget raisedBuy$68 → $80
Nov 6HC Wainwright & Co.Target raisedBuy$70 → $80
Aug 14Canaccord GenuityTarget raisedBuy$60 → $68
Aug 14B. Riley SecuritiesReiteratedBuy$70
Loading…

Technical Analysis

ETON · as of the Nov 17 close · updated after every close
Uptrend

The stock is 12% above its 20 day and 13% above its 50 day average. It is 40% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 61). The nearest support is the Pivot at $63.47, and the nearest resistance the Pivot R1 at $64.75.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNormal
VolatilityHigh, 6.3%/day
Key levels
$70.6452 week high+11.0%
$66.37Swing high (Aug 24)+4.3%
$64.75Pivot R1+1.7%
$63.65Last close
$63.47Pivot−0.3%
$62.36Pivot S1−2.0%
$58.24Swing low (Aug 31)−8.5%
$55.8820 day average−12.2%
$55.4650 day average−12.9%
$51.84100 day average−18.6%
$38.34200 day average−39.8%
$14.2752 week low−77.6%
Indicators
RSI (14)61.18Strong, overbought above 70Neutral
MACD3.03Above its signal lineBullish
Stochastic71.0Middle of its rangeNeutral
ADX (14)26.4Trending up
Williams %R-29.7Oversold below −80, overbought above −20Neutral
CCI (20)83.3Oversold below −100, overbought above 100Neutral
Rate of change+24.9%Change over 10 sessionsBullish
ATR (14)$4.00Typical daily range, 6.3% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for ETON

What happened before

See how ETON did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow ETON usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How ETON has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in ETON in the last 90 days.

Loading…

See today’s whale options flow across the market →

ETON Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲143 buying vs 80 selling
  • ▲Held by funds +3.3 pts
  • ▲Funds holding +49
  • ▼Superinvestors: 1 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding214165+29.7%
In funds' top 1065+20.0%
Held by funds76.6%73.3%+3.3 pts
New / increased72 / 7155 / 57+27.7%
Reduced / sold out53 / 2735 / 5+100.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See ETON institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ETON is in one of them and how their past ETON trades turned out.

ETON in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered ETON in an article yet. Here's the latest on the wider market.

ETON Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Dec 1
Who traded ETON · since 2022
Latest 1 filing
$15K – $50KTraded Oct 11, 2022Filed Dec 1, 2022
PersonTypeAmountTradedFiledDelay
Tom SuozziD · NYBuy$15K – $50KOct 11, 2022Dec 1, 202251 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Eton Pharmaceuticals

Eton develops and sells prescription treatments for rare diseases. Its products include hormone replacement therapies for adrenal insufficiency, a treatment for a childhood growth disorder, and products for metabolic conditions such as phenylketonuria, Wilson disease and tyrosinemia. The company is based in Deer Park, Illinois, and sells its products in the United States through its own sales force. Its products reach patients through specialty pharmacies, and its customers are mainly doctors who treat patients with these conditions.

Headquarters
Deer Park, IL